Latest malaria vaccine news
Recent stories and articles on malaria vaccine developments around the world
(Click on headline to read the full story.)
GlaxoSmithKline launches Africa charity partnership
May 10, 2013 – Britain's biggest drug manufacturer has launched a new partnership with Save the Children to develop medicines to tackle child mortality in Africa.
Opinion pieces published in recognition of World Malaria Day
April 26, 2013 – Wednesday was World Malaria Day, observed annually on April 25. This year's theme was "Invest in the future: defeat malaria." The following is a summary of opinion pieces published in recognition of the day.
Crenshaw and Davis: Ending the scourge of malaria
April 26, 2013 – Although our nation is facing tough fiscal challenges, we have seen incredible returns on some of our investments, particularly in global health, and we simply cannot afford to turn our backs on these commitments now.
The Washington Times
Africa: Malaria - the ongoing fight against an old, adaptive foe
April 25, 2013 – As the global public health community solemnly marks World Malaria Day, attention turns to the human toll enacted by this deadly disease and the measures needed to eradicate it.
Anti-malaria vaccine a few tests away
April 25, 2013 – So far, over 30 vaccine candidates have been discontinued, and researchers are working to improve RTS,S in the hope that, by 2025, the world will have a malaria vaccine that reduces the disease by 80 per cent and protects for longer.
Hope for wiping out malaria vested in vaccines
April 25, 2013 – The last 10 years have seen significant gains in the fight against malaria. Around the world, cases of the disease have dropped—so too the number of deaths. But malaria still kills an estimated 660,000 people every year, most of them African children. The gains are fragile and could easily be reversed. On World Malaria Day, international Geneva correspondent, Vincent Landon, takes a look at where we are in the war on malaria and why new hope is vested in vaccines.
World Radio Switzerland
April 2013: World Malaria Day supplement
April 25, 2013 – Special supplement issued with The Independent on World Malaria Day.
US promotes active surveillance in global fight against malaria
April 24, 2013 – In the 13 years since the United Nations first marked April 25 as World Malaria Day, dramatic progress has been made in preventing, controlling and treating this deadly tropical disease. Experts believe that with improved surveillance and more diligent treatment efforts, the disease could be soon be eradicated.
Voice of America
Decade of Vaccines supplement features PATH contributors
April 18, 2013 – The journal Vaccine has published a special supplement dedicated to the Decade of Vaccines Global Vaccine Action Plan (GVAP) that features articles by PATH contributors and others on the GVAP strategic objectives and the opportunities and challenges associated with its implementation.
PATH press room
Crossing borders: Sub-Saharan Africa is focus of efforts to defeat a killer
March 24, 2013 – The face of malaria today is not children's author Theodor Seuss Geisel's "party gal Ann" but an African child. Malaria is the No. 1 killer of children under age 5.
The Sacramento Bee
Failing vaccine strategies need to be revamped
March 5, 2013 – New approaches are needed to reverse the trend of disappointing vaccines against HIV/AIDS, tuberculosis and malaria, argues biotech expert Thomas Egwang.
The quest to end malaria deaths by 2015: The search for an effective malaria vaccine
February 19, 2013 – Malaria is a treatable and preventable disease. However, the disease continues to claim lives, especially of children under five years of age and pregnant women.
Probing the malarial shape shifters
February 6, 2013 – Developing nano tools to study the parasites at the root of one of the world's greatest health threats.
MIT Industrial Liaison Program
Study of candidate malaria vaccine shows results in Ethiopia
February 6, 2013 – Scientists recently studied the nature of humoral immune responses to a malaria vaccine candidate in two Ethiopian ethnic groups living in malaria-endemic regions.
Vaccine News Daily
European Commission commits to fight against pregnancy-associated malaria
February 6, 2013 – The European Commission recently dedicated six million Euros toward the development of a candidate vaccine against pregnancy-associated malaria.
Vaccine News Daily
Bill Gates: Malaria can be eradicated
January 25, 2013 – Deadly diseases like malaria, tuberculosis and HIV that afflict the world's poorest the most can be eradicated, Microsoft founder Bill Gates said, but he worries austerity measures could clip some public funding.
Intractable malaria parasites made to thrive in human cell culture
January 21, 2013 – Much of what we know about the species of parasite responsible for the malaria widespread in Africa was learnt from studying the parasite's biology and gene expression in human red blood cells in vitro.
Scientists in Benin unveil enhanced malaria test
January 21, 2013 – Researchers in Benin say they have developed an improved method for detecting malaria parasites in mosquito vectors that could help yield better estimates of malaria transmission intensity in different settings.
New plans to improve malaria vaccine
January 19, 2013 – Scientists have started a new project to enhance the malaria vaccine, giving fresh impetus to the fight against the killer disease.
The East African
Here I am: Focus on malaria elimination—an interview with Dr. Roly Gosling
January 17, 2013 – This week, an important meeting on the monitoring and evaluation of malaria control policies is taking place. The Monitoring & Evaluation Reference Group (MERG) meeting, convened by the Roll Back Malaria Partnership is taking place in Namibia. This is an interview with Dr. Roly Gosling, an international expert on malaria who currently leads the Malaria Elimination Initiative at the University of California, San Francisco, Global Health Group.
Funding the future: Getting pharmaceuticals to tackle disease in Africa
January 17, 2013 – The RTS,S trial was not the success the public health community was hoping for—especially given that earlier trials showed 55% efficacy in children between 5 and 17 months. But it is still too early to give up on the vaccine, and more detailed results from the trial are set for release in 2014.
Think Africa Press
Africa: Working toward malaria eradication the "only viable long-term strategy"
January 10, 2013 – Dr. David Brandling-Bennett, deputy director of the malaria programme at the Bill & Melinda Gates Foundation, says that recent success in Zambia is proof that real progress can be made in the fight against malaria. AllAfrica recently spoke with him about current tools being used to fight the disease, the prospect for a vaccine and the hope of new drugs to accelerate progress.
PATH Malaria Vaccine Initiative and Inovio Pharmaceuticals partner to accelerate development of malaria vaccines and innovative delivery technologies
January 7, 2013 – The PATH Malaria Vaccine Initiative (MVI) and Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced a follow-on collaboration to advance malaria vaccine development and new vaccination delivery technologies.
Philadelphia Business Journal
Search for new malaria vaccine begins
January 7, 2013 – A new project to advance malaria vaccine development and new vaccine delivery technologies has been launched.
The Guardian Nigeria
PATH's malaria team partners with Inovio on new vaccine approach
January 7, 2013 – Seattle-based PATH is partnering with Inovio Pharmaceuticals Inc. to work on the global health organization’s Malaria Vaccine Initiative.
Puget Sound Business Journal
Don't mind the mosquito in 2013
January 4, 2013 – Scientists across the world and in Africa are making vast advances on vaccinations and treatments for diseases like malaria and tuberculosis.
The Africa Report